Oramed Pharmaceuticals Inc. (FRA:OJU1)
2.295
-0.045 (-1.92%)
At close: Dec 4, 2025
Oramed Pharmaceuticals Revenue
Oramed Pharmaceuticals had revenue of $2.00M USD in the twelve months ending September 30, 2025.
Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
54.46
Revenue / Employee
$500.00K
Employees
4
Market Cap
92.84M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |